The immune response to pneumococcal polysaccharides 14 and 23F among elderly individuals consists predominantly of switched memory B cells

Journal of Infectious Diseases

Volumn 208, Issue 1, 2013, Pages 101-108

  Leggat, David J ^a   Thompson, Rebecca S ^a   Khaskhely, Noor M ^a   Iyer, Anita S ^a   Westerink, M A Julie ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

23F; B cell; CD27; elderly; flow cytometry; human; Pneumococcus; polysaccharide; Streptococcus pneumoniae; vaccine

Indexed keywords

CD27 ANTIGEN; IMMUNOGLOBULIN M; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS POLYSACCHARIDE 14; PNEUMOCOCCUS POLYSACCHARIDE 23F; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FLUORESCENCE; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE SUBPOPULATION; MEMORY CELL; OPSONIZATION; PHENOTYPE; PRIORITY JOURNAL; VACCINATION;

23F; B CELL; CD27; ELDERLY; FLOW CYTOMETRY; HUMAN; PNEUMOCOCCUS; POLYSACCHARIDE; STREPTOCOCCUS PNEUMONIAE; VACCINE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; B-LYMPHOCYTES; BACTERIAL CAPSULES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; LYMPHOCYTE COUNT; MIDDLE AGED; PNEUMOCOCCAL VACCINES;

EID: 84878600274     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit139     Document Type: Article

References (39)

1. Recommendations of the immunization practices advisory committee pneumococcal polysaccharide vaccine. MMWR 1989; 38:64-8, 73-6.
2. Jackson LA, Neuzil KM, Yu O, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003; 348: 1747-55.
3. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. New Engl J Med 1991; 325:1453-60.
4. Simberkoff MS, Cross AP, Al-Ibrahim M, et al. Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. N Engl J Med 1986; 315:1318-27.
5. Roghmann KJ, Tabloski PA, Bentley DW, Schiffman G. Immune response of elderly adults to pneumococcus: variation by age, sex, and functional impairment. J Gerontol 1987; 42:265-70.
6. Sankilampi U, Honkanen PO, Bloigu A, Leinonen M. Persistence of antibodies to pneumococcal capsular polysaccharide vaccine in the elderly. J Infect Dis 1997; 176:1100-4.
7. Kruetzmann S, Rosado MM, Weber H, et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 2003; 197:939-45.
8. Park S, Nahm MH. Older adults have a low capacity to opsonize pneumococci due to low IgM antibody response to pneumococcal vaccinations. Infect Immun 2011; 79:314-20.
9. Shi Y, Yamazaki T, Okubo Y, Uehara Y, Sugane K, Agematsu K. Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell. J Immunol 2005; 175:3262-7.
10. Kolibab K, Smithson SL, Rabquer B, Khuder S, Westerink MA. Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults: analysis of the variable heavy chain repertoire. Infect Immun 2005; 73:7465-76.
11. Lucas AH, Moulton KD, Tang VR, Reason DC. Combinatorial library cloning of human antibodies to Streptococcus pneumoniae capsular polysaccharides: variable region primary structures and evidence for somatic mutation of Fab fragments specific for capsular serotypes 6B, 14, and 23F. Infect Immun 2001; 69:853-64.
12. Zhou J, Lottenbach KR, Barenkamp SJ, Reason DC. Somatic hypermutation and diverse immunoglobulin gene usage in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae Type 6B. Infect Immun 2004; 72:3505-14.
13. Carsetti R, Rosado MM, Donnanno S, et al. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol 2005; 115:412-7.
14. Timens W, Boes A, Rozeboom-Uiterwijk T, Poppema S. Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response. J Immunol 1989; 143: 3200-6.
15. Weller S, Braun MC, Tan BK, et al. Human blood IgM memory B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 2004; 104:3647-54.
16. Zandvoort A, Timens W. The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens. Clin Exp Immunol 2002; 130:4-11.
17. Khaskhely N, Mosakowski J, Thompson RS, Khuder S, Smithson SL, Westerink MA. Phenotypic analysis of pneumococcal polysaccharidespecific B cells. J Immunol 2012; 188:2455-63.
18. Nahm M. Training manual for enzyme linked immunosorbent assay for the quantitation of Streprococcus pneumoniae serotype specific IgG (Pn PS ELISA), 2006.
19. Kolibab K, Smithson SL, Shriner AK, et al. Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I. Antibody concentrations and influence of pneumococcal polysaccharide 22F absorption. Immun Ageing 2005; 2:10.
20. Romero-Steiner S, Libutti D, Pais LB, et al. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin Diagn Lab Immunol 1997; 4:415-22.
21. Concepcion NF, Frasch CE. Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbant assay. Clin Diagn Lab Immunol 2001; 8:266-72.
22. Moberley SA, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008; CD000422.
23. Lee H, Nahm MH, Kim KH. The effect of age on the response to the pneumococcal polysaccharide vaccine. BMC Infect Dis 2010; 10:60.
24. Romero-Steiner S, Musher DM, Cetron MS, et al. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis 1999; 29:281-8.
25. Schenkein JG, Park S, Nahm MH. Pneumococcal vaccination in older adults induces antibodies with low opsonic capacity and reduced antibody potency. Vaccine 2008; 26:5521-6.
26. Howard WA, Gibson KL, Dunn-Walters DK. Antibody quality in old age. Rejuvenation Res 2006; 9:117-25.
27. Ademokun A,Wu YC, Martin V, et al. Vaccination-induced changes in human B-cell repertoire and pneumococcal IgM and IgA antibody at different ages. Aging cell 2011; 10:922-30.
28. Pneumococcal vaccines: WHO position paper. Wkly Epidemiol Rec 1999; 74:177-83.
29. Fattal-German M, Taillandier J, Mathieu D, Bizzini B. Pneumococcal vaccination of elderly individuals. Vaccine 1991; 9:542-4.
30. Klein U, Rajewsky K, Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 1998; 188:1679-89.
31. Boes M, Prodeus AP, Schmidt T, Carroll MC, Chen J. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 1998; 188:2381-6.
32. Colonna-Romano G, Bulati M, Aquino A, et al. B cells in the aged: CD27, CD5, and CD40 expression. Mech Ageing Dev 2003; 124: 389-93.
33. Frasca D, Landin AM, Lechner SC, et al. Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J Immunol 2008; 180: 5283-90.
34. D'Orsogna LJ, Krueger RG, McKinnon EJ, French MA. Circulating memory B-cell subpopulations are affected differently by HIV infection and antiretroviral therapy. AIDS 2007; 21:1747-52.
35. Hart M, Steel A, Clark SA, et al. Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease. J Immunol 2007; 178:8212-20.
36. Clutterbuck EA, Lazarus R, Yu LM, et al. Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells. J Infect Dis 2012; 205:1408-16.
37. Heilmann C, Pedersen FK. Quantitation of blood lymphocytes secreting antibodies to pneumococcal polysaccharides after in vivo antigenic stimulation. Scand J Immunol 1986; 23:189-94.
38. Kehrl JH, Fauci AS. Activation of human B lymphocytes after immunization with pneumococcal polysaccharides. J Clin Invest 1983; 71: 1032-40.
39. Paradiso PR. Pneumococcal conjugate vaccine for adults: a new paradigm. Clin Infect Dis 2012; 55:259-64.